Exelixis (EXEL) Change in Inventory (2013 - 2026)
Exelixis (EXEL) recorded quarterly Change in Inventory of $3.4 million in Q2 2026, up 124.55% quarter-over-quarter from -$13.8 million in Q1 2026, and up 4673.24% on a YoY basis from $71000.0 in Q2 2025.
Exelixis (EXEL) Change in Inventory (2013 - 2026) Analysis & Trends
Exelixis' Change in Inventory history runs 14 years deep, the most recent figure standing at $3.4 million for Q2 2026.
- In Q2 2026, Change in Inventory rose 4673.24% year-over-year to $3.4 million; the TTM figure through Apr 2026 stood at -$8.9 million (down 142.9% YoY), while the FY2026 annual figure was -$12.2 million, down 124.19% from the prior year.
- Change in Inventory was $3.4 million for Q2 2026 at Exelixis, up from -$13.8 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $8.4 million in Q1 2023 to a low of -$13.8 million in Q1 2026.
- Historically, Change in Inventory has averaged $610058.8 across 5 years, with a median of $1.5 million in 2022.
- Biggest YoY gain for Change in Inventory was 4673.24% in 2026; the steepest drop was 399.86% in 2026.
- A 5-year view of Change in Inventory shows it stood at $1.8 million in 2022, then tumbled by 182.62% to -$1.5 million in 2023, then jumped by 125.16% to $384000.0 in 2024, then soared by 980.47% to $4.1 million in 2025, then declined by 18.32% to $3.4 million in 2026.
- The last three Change in Inventory figures came in at $3.4 million (Q2 2026), -$13.8 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.39 Mn |
| Apr 3, 2026 | 3.39 Mn |
| Jan 2, 2026 | -13.81 Mn |
| Jan 2, 2026 | -13.81 Mn |
| Oct 3, 2025 | 4.15 Mn |
| Oct 3, 2025 | 4.15 Mn |
| Jul 4, 2025 | -2.64 Mn |
| Jul 4, 2025 | -2.64 Mn |
| Apr 4, 2025 | 71,000.00 |
| Apr 4, 2025 | 71,000.00 |
| Jan 3, 2025 | -2.76 Mn |
| Jan 3, 2025 | -2.76 Mn |
| Sep 27, 2024 | 384,000.00 |
| Sep 27, 2024 | 384,000.00 |
| Jun 28, 2024 | -1.36 Mn |
| Jun 28, 2024 | -1.36 Mn |
| Mar 29, 2024 | -1.72 Mn |
| Mar 29, 2024 | -1.72 Mn |
| Dec 29, 2023 | -1.53 Mn |
| Dec 29, 2023 | -1.53 Mn |